← Back to Search

Artificial Tears

Systane® Hydration Eye Drops for Dry Eye Syndrome

N/A
Recruiting
Research Sponsored by Alcon Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up visit 3 (day 30)
Awards & highlights

Study Summary

This trial will assess the performance and safety of eye drops for dry eye relief in different groups of people. Results will be presented by group.

Who is the study for?
This trial is for individuals with mild to moderate dry eye symptoms, including those who wear contact lenses and experience discomfort due to dryness. Participants must understand and sign a consent form. People who've had recent ocular surgery or injury are excluded.Check my eligibility
What is being tested?
The study compares the performance and safety of two eye drop solutions: Systane Hydration PF (preservative-free) for general dry eye, and both Systane Hydration PF & Preserved in contact lens wearers with dryness.See study design
What are the potential side effects?
Potential side effects may include temporary visual disturbances, stinging or burning sensation in the eyes, excessive tearing, eyelid irritation or redness, and possible allergic reactions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~visit 3 (day 30)
This trial's timeline: 3 weeks for screening, Varies for treatment, and visit 3 (day 30) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Mean overall IDEEL-Symptom Bother(SB) score - Group 1
Resultant overall CLDEQ-8 score - Group 2 and Group 3

Trial Design

2Treatment groups
Experimental Treatment
Group I: Systane Hydration PreservedExperimental Treatment1 Intervention
1-2 drops in each eye four times a day for 30 days
Group II: Systane Hydration Preservative Free (PF)Experimental Treatment1 Intervention
1-2 drops in each eye four times a day for 30 days

Find a Location

Who is running the clinical trial?

Alcon ResearchLead Sponsor
704 Previous Clinical Trials
124,376 Total Patients Enrolled
Clinical Lead, Vision CareStudy DirectorAlcon Research, LLC
2 Previous Clinical Trials
135 Total Patients Enrolled

Media Library

Systane® Hydration PF (Artificial Tears) Clinical Trial Eligibility Overview. Trial Name: NCT05932238 — N/A
Dry Eye Syndrome Research Study Groups: Systane Hydration Preservative Free (PF), Systane Hydration Preserved
Dry Eye Syndrome Clinical Trial 2023: Systane® Hydration PF Highlights & Side Effects. Trial Name: NCT05932238 — N/A
Systane® Hydration PF (Artificial Tears) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05932238 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any new participants being sought for this research project?

"Contrary to what is reported on clinicaltrials.gov, this trial is not seeking out any more participants. After the initial posting of July 1st 2023 and an update on June 27th 2023, it has become inactive; however, there are 90 other trials actively recruiting patients at present."

Answered by AI
~45 spots leftby Aug 2024